rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Roper Technologies, Inc.

ROP · Nasdaq

Health CareLife-science toolsJust started moving

ROP stood above a rising 150-day average in 5 of the last 52 weekly readings, including each of the last 2 weeks. It is 9.6% above that average now. Life Science Tools & Research Services: 58% of its 79 stocks in an uptrend (+6 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
2 in a row
Industry in uptrend
58% +6 in 4 wk
Insider buys, 12 months
$6.1M
Insider sales, 12 months
$22.1M
Officials’ trades on record
91

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.

22 Apr – 21 Oct
26%42%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$16.7M$0$4.2MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

91 disclosed lines: House 65, Senate 4, executive 22; 19 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k8 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$50k–$100k24 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$500k–$1M18 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k16 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k12 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k3 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$50k–$100k22 May 2026filed 1 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k15 May 2026filed 8 Jun 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k11 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$250k–$500k17 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k15 Apr 2026filed 1 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k14 Apr 2026filed 8 May 2026

Insiders

Buy orders, 12 months3
Sale orders, 12 months4
Buyers · sellers3 · 4
WhoDidSharesTraded
John K. StipancichEVP, Chief Legal Officer & Secsold2,000at $379.0527 Jul 2026filed 27 Jul 2026
Richard F. WallmanDirectorsold6,434at $361.0024 Jul 2026filed 27 Jul 2026
Thomas Patrick Joyce, Jr.Directorbought1,400at $358.466 Feb 2026filed 6 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Abhijit Dubey Company insiderDirector · last 1 Oct 20260 · 0
Irene M. Esteves Company insiderDirector · last 15 Sep 20260 · 0
Shellye L. Archambeau Company insiderDirector · last 15 Sep 20260 · 1
Thomas Patrick Joyce Jr. Company insiderDirector · last 15 Sep 20261 · 0
John K. Stipancich Company insiderEVP, Chief Legal Officer & Sec · last 27 Jul 20260 · 9
Richard F. Wallman Company insiderDirector · last 24 Jul 20268 · 9
Donald J. Trump Executive branchWhite House Office · last 8 Jul 202613 · 9
Amy Woods Brinkley Company insiderDirector · last 20 May 20261 · 3
John Francis Murphy Company insiderDirector · last 20 May 20260 · 0
Laura G. Thatcher Company insiderDirector · last 20 May 20260 · 1
Robert D. Johnson Company insiderDirector · last 20 May 20260 · 49
Gilbert Ray Cisneros, Jr. HouseCA31 · last 15 May 20262 · 3

Same industry

OABI OmniAbLeading+72%
TXG 10x GenomicsLeading+69%
ILMN IlluminaLeading+53%
AVTR AvantorLeading+52%
RVTY RevvityLeading+39%
ABSI AbsciLeading+36%
MASS 908 DevicesLeading+35%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202569.2%
Operating profit marginFY 2025 · to 31 Dec 202528.3%
Return on capital employedFY 2025 · to 31 Dec 20257.2%
Cash conversionFY 2025 · to 31 Dec 2025165%
Debt to equityFY 2025 · to 31 Dec 20250.50×
Research spendFY 2025 · to 31 Dec 202510.8%
Share count trendFY 2025 · to 20 Feb 2026-3.4%
Cash and equivalentsFY 2025 · to 31 Dec 2025$297.4M

Analyst forecasts

No analyst forecasts yet.